BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9395748)

  • 1. Pharmacological prevention of variceal bleeding. New developments.
    García-Pagán JC; Bosch J
    Baillieres Clin Gastroenterol; 1997 Jun; 11(2):271-87. PubMed ID: 9395748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
    Bosch J
    P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological therapy for portal hypertension: rationale and results.
    Burroughs AK; Panagou E
    Semin Gastrointest Dis; 1995 Jul; 6(3):148-64. PubMed ID: 7551972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variceal bleeding : pharmacological treatment and prophylactic strategies.
    Villanueva C; Balanzó J
    Drugs; 2008; 68(16):2303-24. PubMed ID: 18973395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of portal hypertension.
    Bosch J
    Digestion; 1998 Aug; 59(5):547-55. PubMed ID: 9705538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding.
    Tiani C; Abraldes JG; Bosch J
    Dig Liver Dis; 2008 May; 40(5):318-27. PubMed ID: 18291732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers in the prevention of gastrointestinal bleeding.
    Lebrec L
    Rev Invest Clin; 1990 Jul; 42 Suppl():159-64. PubMed ID: 19256157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
    Schepke M
    Dtsch Med Wochenschr; 2009 Sep; 134(37):1823-7. PubMed ID: 19728251
    [No Abstract]   [Full Text] [Related]  

  • 10. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic treatments for portal hypertension.
    Lo GH
    Hepatol Int; 2018 Feb; 12(Suppl 1):91-101. PubMed ID: 29110128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.
    Grace ND
    Am J Gastroenterol; 1997 Jul; 92(7):1081-91. PubMed ID: 9219775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011973. PubMed ID: 33498095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal varices: prevention of bleeding and rebleeding.
    Lopes GM; Grace ND
    Gastroenterol Clin North Am; 1993 Dec; 22(4):801-20. PubMed ID: 7905864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
    Lo GH; Chen WC; Wang HM; Yu HC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
    Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
    J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.